Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
Hanspeter Brunner(University Hospital of Basel), David J. Webb(Western General Hospital), Stefano Taddei(University of Pisa), Achille C. Pessina(University of Padua), John Deanfield(Universidad de Londres), John Cockcroft(University of Wales), Andrea Natali(Czech Academy of Sciences, Institute of Physiology), Wolfgang Kiowski, Thomas F. Lu ̈scher(University Hospital of Zurich), Gian Paolo Rossi(University of Padua), James Oliver(Western General Hospital), Damiano Rizzoni(University of Brescia), Giuseppe Mancia(University of Milano-Bicocca), Antonio Salvetti(University of Pisa), Ele Ferrannini(University of Pisa), Julian Halcox(Swansea University), Lukas E. Spieker(University Hospital of Zurich), Ann E. Donald(University College Hospital)
Cited by 747
Related Papers
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
|The Lancet|1992|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
|Journal of the American College of Cardiology|2002|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k